Outcomes and Readmissions After Continuous Flow Left Ventricular Assist Device: Heartmate II Versus Heartware Ventricular Assist Device
Articles > Article · 2016
Authors: Osman Nuri TUNCER, CEMAL KEMALOĞLU, OZAN ERBASAN, İLHAN GÖLBAŞI, CENGİZ TÜRKAY, ÖMER BAYEZİD
TRANSPLANTATION PROCEEDINGS, Journal Indexed in SCI Expanded, International, 2016, vol 48, pp 2157-2161
DOI: 10.1016/j.transproceed.2016.03.056
Summary
Introduction. Donor organ shortage is still a problem for heart transplantation. Only 10% of patients in waiting list undergo heart transplantation. Over the last 5 years, 2 different continuous flow pumps, the HeartMate II and the HeartWare, have been successful clinically in the alternative treatment of patients with end-stage heart disease.